Epirubicin dose and sequential hormonal therapy - Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer

Article

Abstract: Background The hormonal manipulation 5-Fluoro-uracil Epirubicin Cyclophosphamide (HMFEC) trial was d

Palabras claves:

adjuvant, Breast Cancer, chemotherapy, Clinical trial, Disease outcome, Hormone manipulation

Autores:

Bliss J.M., Coombes R.C., Faustino R. Pérez-López, Kilburn L.S., Olmos T., Palmieri C., Stebbing J., Tubiana-Mathieu N., Van Bochove A.

Fuentes:

scopus